Dr Subramaniam Arumugam, MD | |
13020 S Winnebago Rd, Palos Heights, IL 60463-2056 | |
(708) 361-2646 | |
Not Available |
Full Name | Dr Subramaniam Arumugam |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 13020 S Winnebago Rd, Palos Heights, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073977369 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 036.045142 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Subramaniam Arumugam, MD 13020 S Winnebago Rd, Palos Heights, IL 60463-2056 Ph: (708) 361-2646 | Dr Subramaniam Arumugam, MD 13020 S Winnebago Rd, Palos Heights, IL 60463-2056 Ph: (708) 361-2646 |
News Archive
Rotech Healthcare Inc. announced today the pricing of its offering of $230 million in aggregate principal amount of Senior Secured Notes due 2015. The notes will be sold to investors at a price of 97.189% of the principal amount thereof and will bear a coupon rate equal to 10 ¾ % per annum. The offering is expected to close on October 6, 2010.
Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA wild-type, according to a study in the October 12 issue of JAMA.
A landmark study published in the Journal of Neuroscience on February 26 reveals that activation of a pregnant mother's immune system can affect her baby's brain development.
Scientists at the National Institutes of Health have developed a mouse model to study the sexual and fetal transmission of Zika virus. This will enable studies to further understanding of how the Zika virus spreads, thereby allowing treatments to be developed.
Glide Pharma today announced that it has entered an agreement with global device manufacturer Nypro Healthcare to complete the design optimisation of its solid dose injector in preparation for production scale up.
› Verified 1 days ago